Advanced therapy financing events in Q1 2019
Interviewee/Contributor
Victoria English
Organisation
MedNous
Research Directory
What ATMP developers need to know about quality
Interviewee/ContributorHouria BachtarziOrganisationERA Consulting (UK) LtdMicrosoft pioneers biological computing
Interviewee/ContributorVictoria EnglishOrganisationMedNousThe role of protein misfolding in human disease
Interviewee/ContributorPeter CharlishOrganisationMedNousSingle-arm studies set the pace of oncology
Interviewee/ContributorBruno PagliaraOrganisationOn-kòs Pharma ConsultingPartial recovery of biotechs
Interviewee/ContributorWilliam EllingtonOrganisationMedNousThe shift towards value-based pricing for medicines
Interviewee/ContributorVictoria EnglishOrganisationMedNousNCI and industry: Moving innovations from the lab to patients
Interviewee/ContributorMichael Salgaller and Michele NewtonOrganisationUS National Cancer InstituteEurope's pharma groups change product mix
Interviewee/ContributorRobin DavisonOrganisationNew Science Global Healthcare FundBuilding capacity in Europe for cell and gene therapy
Interviewee/ContributorYasmin de Faria KrimOrganisationIndependent regulatory affairs professional